APRE - Company ID 0001781983
The table below shows Aprea Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - |
| SG&A |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $1.83M |
| $1.57M |
| $1.82M |
| $1.48M |
| $1.59M |
| $1.76M |
| Operating income | -$5.17M | -$4.03M | -$3.43M | -$3.12M | -$3.39M | -$4.09M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | -$4.81M | -$3.59M | -$3.29M | -$2.97M | -$3.24M | -$3.93M |
| EPS (diluted) | -$0.09 | -$0.07 | -$0.22 | -$0.47 | -$0.53 | -$0.66 |